Other products from "BERKELEY ADVANCED BIOMATERIALS, LLC"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00858418003843 CemO-DZ1040P CemO-DZ1040P Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as blocks (cylinders) that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The blocks (cylinders) may be pressed into the void or into the surgical site by hand. The Cem-Ostetic blocks (cylinders) provide void filling material that acts as a temporary support medium. The blocks (cylinders) are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Cylinder
2 00858418003522 CemO-DZ1030P CemO-DZ1030P Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as blocks (cylinders) that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The blocks (cylinders) may be pressed into the void or into the surgical site by hand. The Cem-Ostetic blocks (cylinders) provide void filling material that acts as a temporary support medium. The blocks (cylinders) are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Cylinder
3 00858418003515 CemO-DZ1020P CemO-DZ1020P Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as blocks (cylinders) that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The blocks (cylinders) may be pressed into the void or into the surgical site by hand. The Cem-Ostetic blocks (cylinders) provide void filling material that acts as a temporary support medium. The blocks (cylinders) are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Cylinder
4 00816125023813 BF-01P BF-01P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Putty
5 00816125023844 BF-10P BF-10P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Putty
6 00816125023837 BF-05P BF-05P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Putty
7 00816125023820 BF-02P BF-02P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Putty
8 00858418003966 SBiO-XYZ400606P SBiO-XYZ400606P SeaSpine Bi-Ostetic Cancellous Blocks is a mixture with a nominal composition of SeaSpine Bi-Ostetic Cancellous Blocks is a mixture with a nominal composition of 60% hydroxyapatite and 40% beta-tri-calcium phosphate. SeaSpine Bi-Ostetic Cancellous Blocks is safe and has excellent biocompatibility. After it is implanted, the implant resorbs and is later replaced by natural bone. SeaSpine Bi-Ostetic Cancellous Blocks is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.SeaSpine Bi-Ostetic Cancellous Blocks is an osteoconductive bone substitute shaped as blocks that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium.The blocks may be pressed into the void or into the surgical site by hand. The SeaSpine Bi-Ostetic Cancellous Blocks provide void filling material that acts as a temporary support medium. The blocks are not intended to provide structural support during the healing process. The implant is radio-opaque. SeaSpine Bi-Ostetic Cancellous Blocks is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 SeaSpine Bi-Ostetic Cancellous Block, 40x6x6mm
9 00858418003935 EBF1-100X25-15 EBF1-100X25-15 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
10 00858418003928 EBF1-100X25-10 EBF1-100X25-10 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
11 00858418003911 EBF1-90X22-07 EBF1-90X22-07 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
12 00858418003904 EBF1-90X22-10 EBF1-90X22-10 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
13 00858418003898 EBF2-50X25-10 EBF2-50X25-10 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
14 00858418003881 EBF2-50X10-05 EBF2-50X10-05 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
15 00858418003874 EBF1-50X10-02 EBF1-50X10-02 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
16 00816125023806 AA-10P AA-10P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
17 00858418003867 EBF2-50X10-02 EBF2-50X10-02 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
18 00858418003850 EBF1-50X10-01 EBF1-50X10-01 EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen EvoGraft is a sterile bone graft composed of purified fibrillar Type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.EvoGraft is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 EvoGraft
19 00858418003829 CemO-00G CemO-00G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
20 00858418003461 CemO-30G CemO-30G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
21 00858418003454 CemO-20G CemO-20G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
22 00858418003447 CemO-15G CemO-15G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
23 00858418003430 CemO-10G CemO-10G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
24 00858418003423 CemO-05G CemO-05G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
25 00858418003416 CemO-02G CemO-02G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
26 00858418003409 CemO-01G CemO-01G Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. Af Cem-Ostetic is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, Cem-Ostetic resorbs and is later replaced by natural bone. Cem-Ostetic is a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.Cem-Ostetic is an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The Cem-Ostetic granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. Cem-Ostetic is biocompatible and resorbs in the body as bone ingrowth occurs. MQV Filler, Bone Void, Calcium Compound 2 Cem-Ostetic Granules
27 00816125023790 AA-05P AA-05P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
28 00816125023783 AA-01P AA-01P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
29 00816125023677 OB-10D OB-10D OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compoun OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, OsteoBoost Select resorbs and is later replaced by natural bone. It provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.OsteoBoost Select is an osteoconductive putty that is intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium.The putty may be shaped and pressed into the void by hand or inserted into a syringe and injected into the surgical site. The paste set in situ or ex situ provides a void filler that can augment hardware to support bone fragments during the surgical procedure. The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. The implant is radio-opaque. It is biocompatible and resorbs in the body as bone in-growth occurs. MQV Filler, Bone Void, Calcium Compound 2 OsteoBoost Select 10cc
30 00816125023639 AA1-100X25-12 AA1-100X25-12 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
31 00816125023622 AA1-50X25-06 AA1-50X25-06 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
32 00816125023592 BF1-100X25-05 BF1-100X25-05 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
33 00816125023585 BF1-50X25-02 BF1-50X25-02 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
34 00816125023578 AA1-100X25-15 AA1-100X25-15 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
35 00816125023561 AA1-50X10-02 AA1-50X10-02 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
36 00816125023554 C10 SB010 C10 SB010 i2b™ Rapid Set is a bio-engineered mixture of calcium-based inorganic compounds. i2b™ Rapid Set is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, i2b™ Rapid Set resorbs and is later replaced by natural bone. It provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.i2b™ Rapid Set is an osteoconductive putty that is intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The putty may be shaped and pressed into the void by hand or inserted into a syringe and injected into the surgical site. The paste set in situ or ex situ provides a void filler that can augment hardware to support bone fragments during the surgical procedure. The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. The implant is radio-opaque. It is biocompatible and resorbs in the body as bone in-growth occurs. MQV Filler, Bone Void, Calcium Compound 2 i2b Rapid Set, 10g
37 00816125023530 AA1-100X25-10 AA1-100X25-10 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
38 00816125023523 AA2-50X10-05 AA2-50X10-05 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
39 00816125023516 AA2-50X10-02 AA2-50X10-02 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
40 00816125023509 AA1-50X10-01 AA1-50X10-01 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Bioactive Glass Foam
41 00816125023400 OB-10P OB-10P OsteoBoost is a bio-engineered mixture of calcium-based inorganic compounds. Aft OsteoBoost is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, OsteoBoost resorbs and is later replaced by natural bone. It provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.OsteoBoost is an osteoconductive putty that is intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium.The putty may be shaped and pressed into the void by hand or inserted into a syringe and injected into the surgical site. The paste set in situ or ex situ provides a void filler that can augment hardware to support bone fragments during the surgical procedure. The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. The implant is radio-opaque. It is biocompatible and resorbs in the body as bone in-growth occurs. MQV Filler, Bone Void, Calcium Compound 2 OsteoBoost, 10 cc
42 00816125021796 BF2-125X20-20 BF2-125X20-20 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
43 00816125021789 BF1-120X20-12 BF1-120X20-12 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
44 00816125021772 BF1-100X25-20 BF1-100X25-20 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
45 00816125021765 BF1-100X25-15 BF1-100X25-15 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
46 00816125021758 BF1-100X25-10 BF1-100X25-10 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
47 00816125021734 BF1-90X22-10 BF1-90X22-10 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
48 00816125021727 BF2-50X25-10 BF2-50X25-10 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
49 00816125021710 BF2-50X20-08 BF2-50X20-08 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
50 00816125021703 BF2-50X15-05 BF2-50X15-05 Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Strip is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Strip is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. MQV Filler, Bone Void, Calcium Compound 2 Bi-Ostetic Foam Strip
Other products with the same Product Codes "MBP, MQV"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 04250971422097 T671CB15-3-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 3 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
2 04250971422080 T671CB15-2-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
3 04250971422073 T671CB15-1-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
4 04250971422066 T672CB03-5-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
5 04250971422059 T672CB03-2-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
6 04250971422042 T672CB03-1-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
7 04250971422035 T672CB0406-30-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
8 04250971422028 T672CB0406-20-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
9 04250971422011 T672CB0406-10-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
10 04250971422004 T672CB0406-5-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
11 04250971421991 T672CB06-10-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
12 04250971421984 T672CB06-5-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
13 04250971421977 T672CB04-10-1 6.2/7.2CB04 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 4 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
14 04250971421960 T672G03-30-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
15 04250971421953 T672G03-20-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
16 04250971421946 T672G03-15-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
17 04250971421939 T672G03-10-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
18 04250971421922 T672G03-5-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
19 04250971421915 T672G03-2-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
20 04250971421908 T672G03-1-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
21 04250971421892 T672G02-30-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
22 04250971421885 T672G02-20-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
23 04250971421878 T672G02-15-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
24 04250971421861 T672G02-10-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
25 04250971421854 T672G02-5-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
26 04250971421847 T672G02-2-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
27 04250971421830 T672G02-1-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
28 04250971421823 T672G01-30-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
29 04250971421816 T672G01-20-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
30 04250971421809 T672G01-15-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
31 04250971421793 T672G01-10-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
32 04250971421786 T672G01-5-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
33 04250971421779 T672G01-2-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
34 04250971421762 T672G01-1-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
35 04250971421755 T71CB15-3-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 3 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
36 04250971421748 T71CB15-2-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 2 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
37 04250971421731 T71CB15-1-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 1 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
38 04250971421724 T72CB03-5-1 7.2CB03 Syntricer® 600 Ceraball®, TCP, diameter 3 mm, 5 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
39 04250971421717 T72CB03-2-1 7.2CB03 Syntricer® 600 Ceraball®, TCP, diameter 3 mm, 2 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
40 04250971421700 T72CB0406-30-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 30 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
41 04250971421694 T72CB0406-20-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 20 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
42 04250971421687 T72CB0406-10-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
43 04250971421670 T72CB06-10-1 7.2CB06 Syntricer® 600 Ceraball®, TCP, diameter 6 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
44 04250971421663 T72CB04-10-1 7.2CB04 Syntricer® 600 Ceraball®, TCP, diameter 4 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
45 04250971421656 T61CB15-3-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 3 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
46 04250971421649 T61CB15-2-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 2 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
47 04250971421632 T61CB15-1-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 1 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
48 04250971421625 T62CB03-5-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 5 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
49 04250971421618 T62CB03-2-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 2 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
50 04250971421601 T62CB0406-30-1 6.2CB0406 Synthacer® 600 Ceraball®, HA, mixture with diameters 4 mm and 6 mm, 30 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT